Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Relmada Therapeutics | RLMD | Jan 17, 2025 | 0.37 | -1.66 |
RELX ADR | RELX | Jan 17, 2025 | 48.17 | +0.54 |
Remitly Global | RELY | Jan 17, 2025 | 23.26 | +0.61 |
Renaissance Ipo ETF | IPO | Jan 17, 2025 | 45.97 | +1.21 |
RenaissanceRe | RNR | Jan 17, 2025 | 257.46 | +0.19 |
RenaissanceRe G Pref | RNR-G | Jan 17, 2025 | 16.52 | -0.69 |
RenaissanceRe Holding F Pref | RNR-F | Jan 17, 2025 | 22.87 | -0.31 |
Renasant | RNST | Jan 17, 2025 | 36.31 | +1.28 |
ReNew Energy Global A Shares | RNW | Jan 17, 2025 | 6.78 | +0.74 |
Renn Fund | RCG | Jan 17, 2025 | 2.65 | -1.49 |
Renovaro Biosciences | RENB | Jan 17, 2025 | 0.71 | -5.73 |
RenovoRx | RNXT | Jan 17, 2025 | 1.50 | +6.38 |
Rent The Runway A | RENT | Jan 17, 2025 | 8.56 | +1.36 |
Rentokil Initial ADR | RTO | Jan 17, 2025 | 23.86 | -0.62 |
Repare Therapeutics | RPTX | Jan 17, 2025 | 1.28 | 0.00 |
Repay A | RPAY | Jan 17, 2025 | 7.37 | -0.67 |
Repligen | RGEN | Jan 17, 2025 | 160.51 | -1.44 |
Replimune Group | REPL | Jan 17, 2025 | 10.14 | -2.12 |
ReposiTrak | TRAK | Jan 17, 2025 | 21.43 | -0.74 |
Republic Bancorp A | RBCAA | Jan 17, 2025 | 68.43 | +1.39 |
Republic Services | RSG | Jan 17, 2025 | 213.73 | +0.85 |
Research Frontiers | REFR | Jan 17, 2025 | 1.66 | -0.59 |
Research Solutions | RSSS | Jan 17, 2025 | 3.65 | -5.44 |
Reservoir Media | RSVR | Jan 17, 2025 | 7.91 | +3.53 |
ReShape Lifesciences | RSLS | Jan 17, 2025 | 4.52 | -3.21 |
Resideo Technologies | REZI | Jan 17, 2025 | 22.96 | -0.26 |
ResMed | RMD | Jan 17, 2025 | 239.78 | +1.12 |
Resources Connection | RGP | Jan 17, 2025 | 8.50 | -0.70 |
Restaurant Brands International | QSR | Jan 17, 2025 | 60.48 | +0.02 |
Retail Bull 3X Direxion | RETL | Jan 17, 2025 | 9.40 | +0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.